This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Alzheimer’s disease (Early onset)
AD_EO
Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2393 |
4. Check minimum number of eventsNone |
2393 |
5. Include endpointsNone |
2393 |
6. Filter based on genotype QC (FinnGen only) |
2078 |
Control definitions (FinnGen only)
- Control exclude
- G6_ALZHEIMER
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Alzheimer’s disease (Early onset)
based on the number of shared cases.
Similar with more cases:
- Alzheimer’s disease (Early onset), excluding more controls
- Alzheimer’s disease, strict definition
- Unspecific neurodegenerative disorder
- Any dementia, excluding more controls
- Any dementia
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2078 | 1027 | 1051 |
| Unadjusted period prevalence (%) | 0.42 | 0.36 | 0.48 |
| Median age at first event (years) | 75.31 | 73.10 | 77.47 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2151
- Matched controls
- 21509
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P70
ICPC
Dementia
14.8
322.1
302
234
P20
ICPC
Memory disturbance
5.6
312.2
824
2143
N06DA02
ATC
donepezil; oral
62.3
307.7
1166
401
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
135.2
307.7
1134
176
G30
ICD-10 Finland
Alzheimer disease
87.5
307.7
248
32
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
83.8
307.7
232
31
G30.1
ICD-10 Finland
Alzheimer disease with late onset
97.4
307.7
994
188
N06DA03
ATC
rivastigmine; oral, transdermal
36.1
307.7
734
304
G30.0
ICD-10 Finland
Alzheimer disease with early onset
13128.5
307.7
1229
*
N05AX08
ATC
risperidone; systemic
10.7
307.7
742
1011
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
1758.6
307.7
785
7
N06DA04
ATC
galantamine; oral
24.8
307.7
317
149
G30.8
ICD-10 Finland
Other Alzheimer disease
62.7
307.7
250
45
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
71.0
307.7
571
109
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.7
307.7
697
1262
N06DX01
ATC
memantine; oral
65.8
307.7
1323
510
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
467.8
307.7
850
30
F0009, G300,
ICD-10 Finland
+∞
295.8
277
*
TAB00
NOMESCO Finland
Lumbar puncture
13.1
281.5
283
245
F03
ICD-10 Finland
Unspecified dementia
6.4
247.7
479
921
XA800
NOMESCO Finland
Neuropsychological investigation
12.6
228.7
234
207
N05AH04
ATC
quetiapine; oral
4.8
213.9
617
1670
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
17.1
210.1
178
113
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
744.6
209.3
203
*
F0019, G301,
ICD-10 Finland
+∞
199.1
188
*
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
84.0
196.2
104
13
F009, G309,
ICD-10 Finland
+∞
139.1
132
*
F06.7
ICD-10 Finland
Mild cognitive disorder
6.5
119.6
208
351
SPAT1053
SPAT
Memory test
3.2
116.2
580
2196
N03AG01
ATC
valproic acid; systemic, rectal
5.3
103.8
224
462
R41.3
ICD-10 Finland
Other amnesia
6.0
86.8
161
288
F05.1
ICD-10 Finland
Delirium superimposed on dementia
13.2
86.6
83
65
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
31.9
86.1
56
18
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
82.9
227
567
Z75.5
ICD-10 Finland
Holiday relief care
8.0
82.5
114
149
N05BA04
ATC
oxazepam; oral
2.5
78.4
742
3805
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.9
77.7
246
683
N05AD01
ATC
haloperidol; systemic
4.4
66.9
180
442
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.4
58.9
232
741
F00
ICD-10 Finland
Dementia in Alzheimer disease
24.0
55.7
40
17
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
541.1
53.8
53
*
N05AH03
ATC
olanzapine; systemic
4.1
53.7
154
396
N05BA06
ATC
lorazepam; systemic, sublingual
3.2
47.2
204
687
WYA20
NOMESCO Finland
Home visit
4.6
44.9
108
242
N06AB10
ATC
escitalopram; oral
2.3
44.8
385
1835
SPAT1234
SPAT
Support of social functional capacity
2.8
41.3
222
844
Z2445
NOMESCO Finland
Psychologist
5.3
41.3
84
163
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
40.8
39
*
A28
ICPC
Limited function/disability NOS
2.0
39.4
608
3606
R53
ICD-10 Finland
Malaise and fatigue
1.9
38.2
642
3913
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
37.9
285
1276
N06AX11
ATC
mirtazapine; oral
1.9
37.3
739
4739
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
36.0
304
1429
N06AB04
ATC
citalopram; systemic
2.0
35.3
514
2973
SPAT1216
SPAT
Assessment of functional ability
2.0
35.2
469
2631
F0029, G308,
ICD-10 Finland
342.4
34.0
34
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
33.9
838
5705
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
33.7
135
433
R41.0
ICD-10 Finland
Disorientation, unspecified
3.2
33.5
140
461
F0014, G301,
ICD-10 Finland
167.5
31.8
33
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.0
31.3
68
140
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
30.3
29
*
N07AA05, ,
ATC
306.6
29.9
30
*
F0004, G300,
ICD-10 Finland
+∞
29.2
28
*
N05AD03
ATC
melperone; systemic
4.2
28.6
78
193
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.8
28.0
149
561
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
27.8
826
5832
G31.0
ICD-10 Finland
Circumscribed brain atrophy
7.7
27.2
38
50
A06AD11
ATC
lactulose; oral
1.8
26.3
529
3345
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.7
26.3
146
562
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
26.3
172
3653
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
26.3
175
737
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
60.8
26.0
30
5
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
136.7
25.7
27
*
SPAT1254
SPAT
Administration of medicine
1.8
24.8
408
2424
F001, G301,
ICD-10 Finland
253.0
24.7
25
*
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
253.0
24.7
25
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.1
23.6
100
332
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
23.5
459
2868
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
23.3
185
842
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
65.7
22.9
26
*
N02AJ06
ATC
codeine and paracetamol; systemic
0.5
22.8
297
5001
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.0
22.7
65
167
N02AA05
ATC
oxycodone; systemic
1.7
22.6
507
3289
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
22.6
407
2481
H04AA01
ATC
glucagon; nasal, parenteral
6.2
22.4
38
62
N06AX26
ATC
vortioxetine; oral
2.7
20.8
119
465
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
111.1
20.6
22
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.4
20.6
141
601
S18
ICPC
Laceration/cut
0.6
20.4
453
6639
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
20.2
408
2561
F000, G300,
ICD-10 Finland
+∞
19.8
19
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
201.8
19.6
20
*
AXX01
NOMESCO Finland
Memory assessment
8.4
19.3
25
30
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
18.6
557
3862
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
18.5
194
985
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
5.5
17.6
34
63
130
Kela drug reimbursment
Malignant tumour
0.2
17.2
35
1336
GD1AA
NOMESCO Finland
Thorax X-ray examination
0.7
16.8
588
7870
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
16.8
58
170
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
16.7
127
2596
F0009, G309,
ICD-10 Finland
+∞
16.7
16
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.5
16.6
191
3389
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
171.3
16.5
17
*
S72.0
ICD-10 Finland
Fracture of neck of femur
2.0
16.2
177
912
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
6.6
16.2
26
40
R55
ICD-10 Finland
Syncope and collapse
1.7
15.8
294
1797
F0001, G300,
ICD-10 Finland
+∞
15.6
15
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
15.2
417
2814
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
15.2
151
2818
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
14.9
115
2345
N06AB06
ATC
sertraline; oral
2.0
14.7
169
887
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.5
14.5
88
355
SPAT1251
SPAT
Organisation of medication
2.2
14.5
123
576
L17
ICPC
Foot/toe symptom/complaint
0.6
14.4
239
3841
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
14.4
168
2982
LAITO, ,
NOMESCO Finland
12.8
13.9
24
19
M79.6
ICD-10 Finland
Pain in limb
0.6
13.9
410
5749
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
75.6
13.6
15
*
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
13.6
13
*
A10AB05
ATC
insulin aspart; parenteral
1.9
13.3
168
910
E86
ICD-10 Finland
Volume depletion
2.4
13.1
91
391
SPAT1153
SPAT
Removal of sutures
0.6
12.9
277
4186
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
12.6
153
2694
F0002, G300,
ICD-10 Finland
+∞
12.5
12
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.6
12.4
186
3084
K86
ICPC
Hypertension uncomplicated
0.5
12.0
92
1888
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.1
12.0
112
544
Z28
ICPC
Limited function/disability (Z)
5.3
12.0
24
46
SPAT1229
SPAT
Assessment of need for aid
1.8
11.7
198
1174
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
11.7
204
3255
207
Kela drug reimbursment
Chronic arrhythmias
0.6
11.7
199
3195
AA1CG, ,
SPAT
4.9
11.7
25
51
SPAT1301
SPAT
No procedures
1.4
11.6
585
4452
-, ,
ICD-10 Finland
2.6
11.6
65
253
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.5
11.5
73
301
F0001, G301,
ICD-10 Finland
+∞
11.5
11
*
N07AA06, ,
ATC
+∞
11.5
11
*
F0011, G301,
ICD-10 Finland
+∞
11.5
11
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
11.5
11
*
F22.0
ICD-10 Finland
Delusional disorder
3.5
11.4
39
114
SPAT1172
SPAT
Guidance concerning hydration
2.3
11.4
82
359
F05.9
ICD-10 Finland
Delirium, unspecified
2.4
11.4
78
334
B01AF02
ATC
apixaban; oral
0.5
11.3
127
2292
WW200, ,
SPAT
0.6
11.2
223
3443
Z29
ICPC
Social problem NOS
2.9
10.8
51
181
L57.0
ICD-10 Finland
Actinic keratosis
0.5
10.6
98
1887
H02AB02
ATC
dexamethasone; systemic
0.4
10.5
54
1293
R06.0
ICD-10 Finland
Dyspnoea
0.7
10.5
326
4572
Q90.9
ICD-10 Finland
Down syndrome, unspecified
+∞
10.4
10
*
SPAT1360
SPAT
Extensive global examination
1.9
10.4
137
753
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.0
10.4
109
555
C03DA01
ATC
spironolactone; oral
0.6
10.3
144
2444
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.2
10.3
21
41
GD1AA, ,
SPAT
0.4
10.3
46
1170
S70.0
ICD-10 Finland
Contusion of hip
2.0
10.3
114
592
N02BE01
ATC
paracetamol; systemic, rectal
1.4
10.2
1675
15313
J01CA08
ATC
pivmecillinam; oral
1.4
10.2
783
6365
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.1
10.2
27
66
OAB93, ,
SPAT
2.7
10.1
54
205
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
8.5
10.0
21
25
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.6
9.9
233
3474
AXX01, ,
SPAT
2.2
9.9
82
381
M01AH05
ATC
etoricoxib; oral
0.7
9.8
625
7746
N05AH02
ATC
clozapine; systemic
4.7
9.8
22
47
JN4AD
NOMESCO Finland
Body CT examination
0.4
9.8
64
1391
WX402
NOMESCO Finland
General anaesthesia
0.5
9.6
118
2077
L03
ICPC
Low back symptom/complaint
0.6
9.6
216
3251
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
15.1
9.5
15
10
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.8
9.5
47
172
F0003, G300,
ICD-10 Finland
+∞
9.4
9
*
R05
ICPC
Cough
0.6
9.4
176
2767
L28
ICPC
Limited function/disability (L)
1.4
9.4
457
3439
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
9.3
276
1882
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.5
9.3
58
238
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
9.3
273
3884
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
9.3
157
932
L08
ICPC
Shoulder symptom/complaint
0.6
9.2
165
2627
K85
ICPC
Elevated blood pressure
0.6
9.1
149
2429
SPAT1252
SPAT
Overall medication plan or its review
1.7
9.1
162
975
N02AX02
ATC
tramadol; systemic, rectal
0.7
9.0
572
7114
W19
ICD-10 Finland
Unspecified fall
1.6
8.9
212
1375
C08CA01
ATC
amlodipine; oral
0.7
8.9
573
7119
AA1AD
NOMESCO Finland
CT of head and brain
1.4
8.9
616
4905
A10BK03
ATC
empagliflozin; oral
0.4
8.9
48
1125
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.8
94
482
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
8.7
185
1167
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.0
8.7
94
484
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
14.1
8.7
14
10
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
8.7
199
1279
C04AE01
ATC
ergoloid mesylates; systemic
3.1
8.7
35
114
C09CA06
ATC
candesartan; oral
0.6
8.6
215
3171
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.0
8.6
36
120
R03AC02
ATC
salbutamol; inhalant
0.7
8.5
647
7858
H02AB06
ATC
prednisolone; systemic
0.7
8.4
642
7799
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
90.4
8.4
9
*
F0009, G301,
ICD-10 Finland
+∞
8.3
8
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
8.3
254
1743
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.6
8.3
45
173
E000001, ,
ATC
1.4
8.3
343
2501
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.4
8.3
48
1093
EB1VA, ,
NOMESCO Finland
0.5
8.2
77
1473
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
4.8
8.1
18
38
L15
ICPC
Knee symptom/complaint
0.6
8.1
199
2946
N03AX14
ATC
levetiracetam; systemic
2.4
8.0
53
224
R4110
NOMESCO Finland
Physiotherapy
0.7
8.0
279
3850
N28
ICPC
Limited function/disability (N)
2.7
7.9
40
148
S06.0
ICD-10 Finland
Concussion
1.6
7.8
197
1296
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
0.1
7.8
*
251
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.2
7.6
65
307
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.5
7.6
60
1218
F009, F03,
ICD-10 Finland
25.1
7.6
10
*
N02BF01
ATC
gabapentin; oral
0.4
7.6
44
1001
R4110, ,
SPAT
0.5
7.5
78
1446
P28
ICPC
Limited function/disability (P)
4.3
7.5
19
45
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
7.4
259
1826
A02BC02
ATC
pantoprazole; systemic
0.8
7.4
1006
11398
H81
ICPC
Excessive ear wax
0.6
7.4
177
2637
A04AA01
ATC
ondansetron; systemic, rectal
0.4
7.3
35
863
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.2
7.3
56
253
F009, G300,
ICD-10 Finland
+∞
7.3
7
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.6
7.3
40
155
EB4VA, ,
NOMESCO Finland
0.5
7.2
56
1142
TQW40, ,
SPAT
0.4
7.2
38
896
N05CD07
ATC
temazepam; oral
1.4
7.1
338
2521
WZC30
NOMESCO Finland
Teaching
0.6
7.1
106
1772
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.2
7.1
8
363
P06
ICPC
Sleep disturbance
0.5
7.0
49
1040
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.2
7.0
9
379
S06.2
ICD-10 Finland
Diffuse brain injury
3.5
7.0
23
66
SPAT1101
SPAT
Orthostatic test
1.7
7.0
114
671
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
7.0
310
2286
A10AE04
ATC
insulin glargine; parenteral
1.6
7.0
185
1231
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.5
6.9
42
171
XX3DW
NOMESCO Finland
Time consuming IT work
0.5
6.9
60
1179
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.5
6.9
82
1457
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
6.8
195
2801
L13
ICPC
Hip symptom/complaint
0.7
6.7
172
2531
Z01.7
ICD-10 Finland
Laboratory examination
0.6
6.7
107
1756
J01EA01
ATC
trimethoprim; systemic
1.3
6.7
567
4621
M54.5
ICD-10 Finland
Low back pain
0.7
6.6
346
4477
R74
ICPC
Upper respiratory infection acute
0.6
6.6
165
2440
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.5
6.6
75
1350
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
0.6
6.6
82
1438
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
8.7
6.5
13
15
A04
ICPC
Weakness/tiredness general
1.4
6.5
305
2267
TDA90, ,
SPAT
0.4
6.5
27
709
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.5
6.4
40
165
S21
ICPC
Skin texture symptom/complaint
0.6
6.4
105
1715
H29
ICPC
Ear symptom/complaint other
0.6
6.4
81
1418
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
6.4
38
856
S29
ICPC
Skin symptom/complaint other
0.7
6.3
161
2374
I48.2
ICD-10 Finland
Chronic atrial fibrillation
0.4
6.3
27
698
ZXY02
NOMESCO Finland
Neuropsychologist
8.2
6.3
13
16
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
0.6
6.3
81
1409
C07AB07
ATC
bisoprolol; oral
0.8
6.3
865
9870
I50.1
ICD-10 Finland
Left ventricular failure
0.5
6.3
59
1128
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
6.3
150
976
F0010, G300,
ICD-10 Finland
+∞
6.3
6
*
F0019, G300,
ICD-10 Finland
+∞
6.3
6
*
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
+∞
6.3
6
*
F0023, G308,
ICD-10 Finland
+∞
6.3
6
*
F0024, G308,
ICD-10 Finland
+∞
6.3
6
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.0
6.2
17
43
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.1
6.2
24
77
C10AX09
ATC
ezetimibe; oral
0.6
6.2
117
1840
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.8
6.1
683
7996
DFF00
NOMESCO Finland
Pure tone audiometry
0.5
6.1
74
1310
SCA02
NOMESCO Finland
Preventive oral health care
1.7
6.1
114
697
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
0.5
6.1
69
1246
N05AN01
ATC
lithium; oral
2.6
6.1
32
122
JN4BD
NOMESCO Finland
Extensive body CT
0.6
6.0
76
1330
K80
ICPC
Cardiac arrhythmia NOS
0.5
6.0
46
942
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
299
59
58.70
307.65
1.0
1.1
56.60
26.05
ng/l
13.48
244
35
294
59
57.56
307.65
1.0
1.0
410.84
212.92
ng/l
14.09
244
37
299
59
58.70
307.65
1.0
1.0
553.34
816.69
ng/l
4.14
244
36
297
285
11.93
276.27
1.1
1.3
437.47
608.70
mg/l
4.78
285
277
280
247
12.88
275.13
1.2
1.3
107.45
939.12
e6/l
0.97
214
202
280
252
12.62
271.55
1.1
1.2
3.84
3.86
mmol/l
0.09
269
239
274
242
12.83
268.90
1.1
1.3
2.17
31.82
e6/l
1.43
196
187
103
182
5.89
56.04
3.5
4.9
323.32
342.49
umol/l
0.55
87
156
50
49
10.42
44.97
1.1
1.2
—
76.33
%
—
0
9
62
91
6.99
40.37
1.0
1.0
—
—
—
0
0
990
12981
0.56
37.12
4.3
5.2
1.51
1.46
mmol/l
3.44
879
11684
1004
13105
0.56
36.91
4.4
5.3
4.56
4.46
mmol/l
1.83
900
11918
1047
13447
0.57
35.36
4.9
6.1
2.64
2.55
mmol/l
2.40
934
12153
947
12494
0.57
35.29
3.8
4.4
1.20
1.28
mmol/l
3.46
830
11140
585
3597
1.86
33.04
1.8
1.9
1175.57
1167.27
nmol/l
0.08
433
2714
296
5287
0.49
28.59
1.9
1.9
1.24
1.32
mmol/l
1.09
257
4356
1076
13120
0.64
22.31
6.4
7.2
41.45
40.67
mmol/mol
1.30
937
11989
340
5455
0.55
21.94
3.6
4.0
5.98
10.80
mg/mmol
1.65
210
3380
332
5328
0.55
21.31
2.9
3.3
6.91
6.85
mmol/l
0.09
266
4390
1108
13371
0.65
21.29
4.6
5.6
6.25
6.11
mmol/l
1.45
971
11924
1087
13142
0.65
20.76
17.3
20.2
73.70
70.46
ml/min/173m2
5.94
994
12316
496
7089
0.61
20.08
2.4
2.9
—
—
estimate
—
0
0
36
67
5.45
18.56
1.0
1.1
35.34
44.12
mg/l
0.62
29
56
660
8626
0.66
16.75
7.5
8.8
4.50
4.35
e9/l
0.69
561
7401
460
6472
0.63
16.47
10.4
12.5
0.00
0.00
e9/l
0.22
363
5225
98
2196
0.42
16.39
1.2
1.3
17.93
13.46
u/ml
0.23
37
763
459
6437
0.64
16.10
3.1
3.5
2206.62
2256.16
ng/l
0.06
379
5600
27
48
5.68
14.62
1.1
1.1
15.00
312.68
ng/l
—
6
13
27
50
5.46
14.01
1.2
1.2
0.58
0.49
ratio
0.92
15
30
281
4278
0.61
13.61
2.1
2.9
336.34
364.13
umol/l
3.53
233
3634
30
63
4.81
13.55
1.0
1.0
—
—
—
0
0
126
2354
0.51
12.56
1.2
1.3
19.12
35.82
iu/ml
2.89
39
751
1274
14390
0.72
12.06
9.2
12.6
23.35
24.47
u/l
0.81
1186
13841
264
3964
0.62
11.83
2.1
2.5
—
—
—
0
0
120
2212
0.52
11.41
2.4
3.9
233.84
253.33
u/l
1.14
102
2073
353
4902
0.67
10.86
3.3
3.6
0.52
0.52
e6/l
0.01
273
3721
703
8621
0.73
10.60
4.0
6.1
12.54
12.74
umol/l
0.12
642
8172
926
10886
0.74
10.58
3.7
4.5
13.18
15.63
mm/h
5.01
819
10047
174
2812
0.59
10.40
2.3
2.6
21.51
20.60
%
0.40
143
2588
191
3009
0.60
10.31
2.1
2.6
2.23
2.25
g/l
0.22
162
2754
534
6814
0.71
10.17
2.6
3.1
133.09
144.82
ug/l
0.72
467
6173
128
696
1.89
10.06
1.3
1.3
25.40
54.72
au/ml
—
6
52
147
2457
0.57
9.95
4.6
5.1
1.03
1.05
mmol/l
0.42
132
2235
212
3220
0.62
9.78
2.2
2.6
12.15
11.52
umol/l
0.58
180
2965
488
3734
1.40
9.04
1.8
1.8
447.26
17848121.76
pmol/l
2.15
408
3020
93
1727
0.52
8.99
4.9
6.0
12.22
12.22
mmol/l
0.00
83
1625
135
776
1.79
8.90
2.3
2.5
19.48
18.93
au/ml
—
9
57
952
11001
0.76
8.89
21.7
24.9
13.86
14.03
%
3.13
928
10792
151
2431
0.59
8.80
1.6
1.5
2.58
2.64
g/l
0.13
82
1416
230
3353
0.65
8.73
1.6
1.7
1.87
1.48
mg/l
0.34
159
2639
27
75
3.63
8.56
1.1
1.1
—
—
—
0
0
202
3013
0.64
8.51
3.1
3.2
1.51
1.36
e6/l
0.21
108
1661
95
1715
0.53
8.37
1.8
2.5
65.46
65.69
g/l
0.11
81
1531
23
58
4.00
8.33
1.1
1.0
1.00
1.21
u/l
1.02
11
31
186
2813
0.63
8.32
3.2
3.4
3.57
2.38
e6/l
0.67
91
1454
197
2907
0.65
7.85
2.2
2.9
0.83
0.82
mmol/l
1.10
182
2676
300
4061
0.70
7.66
3.3
4.2
85.61
83.44
%
0.70
284
3955
118
1952
0.58
7.61
2.3
3.8
13.49
18.72
ug/l
0.24
96
1628
1047
11802
0.78
7.36
5.3
8.0
82.07
84.08
u/l
0.30
944
11045
744
8730
0.77
7.15
3.0
3.3
46.03
56.56
u/l
3.27
672
8018
35
131
2.70
6.84
1.4
1.3
—
—
—
0
0
118
1875
0.61
6.48
2.0
2.5
63.38
68.29
e9/l
1.06
94
1409
265
1925
1.43
6.48
8.6
8.9
—
—
—
0
0
38
848
0.44
6.26
1.2
2.1
4.00
3.71
g/l
0.76
32
755
39
850
0.45
6.05
1.2
2.1
4.21
4.17
g/l
0.10
33
756
39
850
0.45
6.05
1.2
2.1
7.71
7.60
g/l
0.12
33
757
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
73
3.17
6.02
1.2
1.2
—
—
—
0
0
99
1604
0.60
5.89
1.6
2.0
0.20
0.20
g/l
0.26
88
1470
375
4718
0.75
5.83
2.6
3.1
34.58
35.59
u/l
0.15
354
4422
216
2963
0.70
5.82
2.8
3.5
0.99
0.85
ug/l
0.41
146
2033
269
3542
0.73
5.66
3.5
4.6
323.55
315.42
ng/l
0.02
217
3110
85
1415
0.58
5.63
1.2
1.4
—
—
—
0
0
466
5670
0.77
5.61
3.4
3.7
91.23
84.00
e6/l
0.09
365
4435
36
782
0.45
5.56
1.3
2.2
3.07
3.06
g/l
0.02
30
687
1169
12792
0.81
5.34
4.8
5.4
1.90
2.05
mu/l
1.19
1030
11533
35
749
0.46
5.21
1.3
2.2
10.58
10.59
g/l
0.01
29
650
328
4139
0.76
5.14
3.4
3.6
0.15
0.06
0.51
20
194
442
3597
1.29
5.10
5.2
4.8
1.02
1.02
kg/l
0.40
279
2451
17
50
3.42
5.02
1.1
1.2
—
—
—
0
0
441
3595
1.29
5.01
2.4
3.0
2.44
2.47
mmol/l
6.29
368
3166
65
1120
0.57
4.92
8.3
8.0
24.67
24.47
mmol/l
0.24
59
1074
73
1216
0.59
4.87
2.8
3.0
64.18
59.25
ml/min/173m2
0.61
28
566
64
1102
0.57
4.84
6.1
7.0
25.00
24.88
mmol/l
0.11
64
1094
31
672
0.45
4.80
2.3
3.0
1.17
5.05
ratio
1.74
24
409
528
6218
0.80
4.67
4.0
4.3
300.24
133.09
e6/l
0.73
376
4580
58
1014
0.56
4.64
1.4
1.7
1.57
1.54
g/l
0.07
40
871
127
1840
0.67
4.58
1.9
2.6
9.47
10.10
umol/l
0.11
100
1613
15
37
4.08
4.40
1.1
1.1
—
—
—
0
0
15
38
3.97
4.29
1.1
1.1
—
—
—
0
0
414
4966
0.79
4.25
2.2
2.4
3.10
3.10
mg/l
0.01
334
4209
135
1903
0.69
4.22
4.4
5.0
33.76
33.47
%
0.12
83
1201
661
5757
1.21
4.05
2.3
3.4
2.35
2.35
mmol/l
0.62
578
5142
140
1944
0.70
4.03
7.8
6.8
94.70
94.98
%
0.17
135
1872
36
690
0.51
3.96
1.6
2.9
849.67
6476.91
u/ml
0.78
31
587
766
8582
0.83
3.94
16.2
20.6
1.38
1.40
inr
0.36
653
7264
14
37
3.80
3.89
1.1
1.1
—
—
—
0
0
16
54
2.98
3.85
3.4
3.0
30.14
30.52
umol/l
—
7
37
14
39
3.61
3.69
1.1
1.1
—
—
—
0
0
36
671
0.53
3.65
3.7
2.5
—
—
—
0
0
164
2180
0.73
3.63
7.3
6.6
1.28
1.16
mmol/l
0.16
131
1764
165
2187
0.73
3.59
7.2
6.6
11.94
11.66
kpa
0.24
153
2081
26
117
2.24
3.58
2.5
2.5
—
—
—
0
0
165
2186
0.73
3.58
7.2
6.6
5.03
5.11
kpa
0.43
153
2079
6
211
0.28
3.49
3.3
3.5
—
—
—
0
0
6
210
0.28
3.49
1.0
1.1
—
—
—
0
0
6
214
0.28
3.47
1.0
1.2
1.68
1.57
g/l
—
6
214
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
727
0.57
3.33
2.3
2.5
0.35
0.36
iu/ml
0.06
23
408
984
10692
0.85
3.30
3.7
4.3
15.04
15.13
pmol/l
0.53
863
9573
11
310
0.35
3.26
1.0
1.2
—
337.78
—
0
27
1401
14795
0.85
3.25
25.8
30.2
242.07
242.06
e9/l
0.00
1327
14388
427
4977
0.82
3.23
4.3
6.0
3.51
4.71
ug/l
0.62
370
4402
17
66
2.59
3.21
1.2
1.2
—
—
—
0
0
1402
14798
0.85
3.20
25.9
30.5
129.60
130.22
g/l
0.80
1339
14543
1402
14796
0.85
3.19
25.7
30.2
4.30
4.32
e12/l
1.11
1322
14319
1402
14795
0.85
3.18
25.6
30.2
91.57
91.84
fl
1.34
1342
14520
1402
14795
0.85
3.18
26.1
30.7
38.40
38.84
%
1.53
1339
14513
103
1445
0.70
3.18
3.1
3.5
88.53
98.40
ng/l
0.47
79
1192
1403
14802
0.85
3.16
25.8
30.2
7.07
6.99
e9/l
0.55
1322
14325
13
40
3.26
3.13
1.2
1.1
—
—
—
0
0
71
1066
0.65
3.12
1.9
2.8
10.04
10.83
g/l
1.40
61
970
54
330
1.65
3.06
1.9
2.7
30.41
33.84
umol/l
0.33
46
287
73
1082
0.66
3.02
1.5
1.4
—
—
—
0
0
31
564
0.54
2.96
1.5
1.9
42.08
39.02
u/l
0.40
25
483
342
4038
0.82
2.93
2.8
2.9
6.68
5.08
e6/l
1.26
310
3678
8
17
4.72
2.92
1.1
1.1
—
—
—
0
0
70
1036
0.66
2.89
3.6
4.1
1.02
1.02
ratio
1.21
58
937
1399
14722
0.86
2.87
22.3
27.1
81.36
84.97
umol/l
3.54
1329
14438
146
1106
1.34
2.86
1.6
1.7
1.61
1.55
%
0.33
126
929
11
289
0.38
2.84
1.2
1.7
—
—
—
0
0
7
204
0.34
2.79
3.0
2.6
—
1671.41
—
0
22
24
463
0.51
2.79
1.4
1.4
—
—
—
0
0
102
1398
0.72
2.78
1.4
1.3
—
—
—
0
0
879
9548
0.87
2.74
4.8
5.0
7.15
6.88
mmol/l
2.16
818
9110
29
520
0.55
2.66
1.2
1.8
5.70
7.43
iu/ml
—
8
128
12
41
2.94
2.62
2.3
2.3
—
—
—
0
0
165
2087
0.77
2.60
2.9
3.3
5.83
5.82
kpa
0.04
158
2019
29
515
0.56
2.58
1.6
1.5
—
—
—
0
0
136
1041
1.33
2.52
1.6
1.5
—
—
—
0
0
111
1475
0.74
2.51
1.9
2.4
74.53
40.21
u/l
0.33
90
1231
22
417
0.52
2.45
1.7
1.6
—
—
—
0
0
828
7604
1.14
2.40
2.3
2.3
96.75
93.61
pmol/l
1.04
428
3982
22
412
0.53
2.37
1.7
1.6
—
—
—
0
0
7
17
4.13
2.36
1.1
1.1
—
—
—
0
0
9
216
0.41
2.31
1.2
1.6
—
—
—
0
0
609
6721
0.87
2.27
2.7
2.4
—
—
—
0
0
42
654
0.64
2.27
3.2
3.3
0.81
0.85
nmol/l
0.24
32
530
23
415
0.55
2.21
1.5
1.5
—
—
—
0
0
11
41
2.69
2.20
2.4
2.3
—
—
—
0
0
230
2746
0.82
2.20
1.2
1.2
2.23
1.57
u/ml
0.21
63
720
138
1743
0.78
2.18
2.6
3.4
213.40
316.81
ng/l
2.68
121
1581
13
277
0.47
2.09
1.5
1.5
—
—
—
0
0
14
290
0.48
2.08
1.6
1.4
12225.62
49774.58
e6/l
—
8
168
14
290
0.48
2.08
1.4
1.5
—
—
—
0
0
166
2029
0.80
2.00
2.9
3.3
1.98
1.89
mmol/l
0.13
143
1700
91
685
1.34
1.95
1.2
1.3
—
—
—
0
0
17
321
0.53
1.93
1.8
1.4
1074.58
1406.44
e6/l
0.37
12
223
1397
14549
0.89
1.93
21.5
25.0
3.99
4.01
mmol/l
1.40
1328
14168
67
919
0.72
1.91
2.5
2.3
12.16
12.07
nmol/l
0.04
61
796
20
358
0.55
1.91
1.1
3.0
15.75
1125.67
u/ml
0.91
15
331
757
8163
0.89
1.90
4.7
4.6
0.05
0.18
estimate
0.36
126
1747
21
370
0.56
1.90
1.3
1.3
3.32
6.49
u/ml
—
5
56
115
1457
0.78
1.89
1.9
2.1
101.98
147.52
ug/g
1.60
84
1156
14
279
0.50
1.88
1.3
1.2
—
46.79
—
0
24
136
1686
0.79
1.87
5.2
6.2
1.56
1.38
mmol/l
1.13
129
1638
48
693
0.69
1.84
1.2
1.2
55.33
133.33
u/ml
2.40
23
243
21
366
0.57
1.83
1.1
1.2
—
—
—
0
0
1397
14530
0.89
1.82
21.5
24.8
140.04
139.41
mmol/l
11.50
1330
14170
372
4192
0.86
1.82
3.8
4.1
0.57
0.08
estimate
0.46
97
1347
17
314
0.54
1.81
2.3
4.1
0.77
1.58
%
0.77
11
273
8
181
0.44
1.81
1.1
1.0
—
—
—
0
0
9
35
2.58
1.80
1.1
1.1
—
—
—
0
0
54
757
0.71
1.77
2.9
3.2
4.28
4.39
pmol/l
0.37
47
659
40
592
0.67
1.76
1.1
1.1
—
2.20
—
0
5
466
5146
0.88
1.70
2.2
2.5
1395.60
77.33
u/l
0.49
424
4736
16
293
0.54
1.68
1.8
1.5
—
—
—
0
0
563
5144
1.13
1.68
1.7
1.8
20.51
19.79
nmol/l
0.51
494
4308
111
1387
0.79
1.66
1.7
2.1
412.54
393.15
nmol/l
0.43
91
1255
6
19
3.16
1.66
1.2
1.2
—
—
—
0
0
746
8002
0.90
1.65
4.8
4.5
0.00
0.00
estimate
0.50
132
1768
24
390
0.61
1.63
2.0
2.7
16.04
15.70
%
0.23
24
382
10
44
2.28
1.55
1.2
1.0
1726.90
1560.39
miu/ml
—
10
44
359
4009
0.87
1.55
4.2
4.9
21.18
22.14
%
0.56
176
2096
11
219
0.50
1.52
1.1
1.1
—
1.07
—
0
6
11
219
0.50
1.52
2.1
1.7
12.77
19.93
ug/l
4.40
11
210
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
5
129
0.39
1.48
1.4
1.5
—
—
—
0
0
5
129
0.39
1.48
1.4
1.5
—
—
—
0
0
5
129
0.39
1.48
1.4
1.5
—
—
—
0
0
31
463
0.66
1.47
1.2
1.3
—
—
—
0
0
55
403
1.37
1.46
3.6
3.8
35.20
29.91
mg/l
0.38
44
306
21
341
0.61
1.45
1.7
1.5
—
—
—
0
0
148
1761
0.83
1.43
2.5
2.8
4.15
4.39
kpa
0.99
140
1698
19
314
0.60
1.41
1.3
2.0
13.79
5.10
mg/l
0.69
14
250
14
251
0.55
1.41
1.6
1.5
—
—
—
0
0
9
40
2.26
1.40
1.4
1.1
—
—
—
0
0
25
385
0.65
1.38
1.7
1.5
—
—
—
0
0
5
122
0.41
1.37
1.0
1.5
—
—
—
0
0
13
68
1.92
1.33
1.4
1.2
—
—
—
0
0
7
147
0.47
1.32
1.3
1.6
—
—
—
0
0
21
331
0.63
1.30
1.5
1.8
1.75
4.34
iu/l
—
10
131
6
24
2.50
1.30
1.2
1.1
1.18
1.16
mmol/l
—
6
24
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
765
8110
0.91
1.27
4.6
4.5
9.46
4.12
estimate
0.24
141
1841
36
506
0.71
1.27
2.0
1.7
—
—
—
0
0
14
77
1.82
1.25
1.0
1.2
—
—
—
0
0
104
1262
0.82
1.25
2.5
3.0
127.90
125.69
g/l
0.63
104
1226
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
21
324
0.64
1.20
1.2
1.2
—
—
—
0
0
6
127
0.47
1.16
1.0
1.2
89.33
100.68
pmol/l
—
6
127
6
129
0.46
1.16
1.0
1.3
—
—
—
0
0
1357
13996
0.92
1.16
18.2
20.4
31.31
27.78
mg/l
2.31
1131
12032
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
69
867
0.79
1.15
2.2
1.9
1.35
2.20
ug/l
0.51
51
737
13
222
0.58
1.14
1.2
1.6
—
—
—
0
0
5
113
0.44
1.12
1.4
1.8
97.20
111.01
ng/l
—
5
113
122
1427
0.85
1.03
2.4
3.9
1.23
1.23
mmol/l
0.56
101
1226
112
1318
0.84
1.01
1.8
1.8
—
—
—
0
0
9
48
1.88
1.00
1.0
1.2
—
—
—
0
0
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
60
480
1.26
0.94
1.5
1.4
—
—
—
0
0
60
480
1.26
0.94
1.5
1.4
—
—
—
0
0
110
1284
0.85
0.92
2.4
3.6
5.15
5.19
kpa
0.24
98
1207
29
388
0.74
0.83
2.8
4.7
5.20
5.02
kpa
0.38
29
381
11
65
1.70
0.82
1.9
2.5
4.59
4.86
kpa
0.46
11
65
11
65
1.70
0.82
1.9
2.5
9.89
9.86
kpa
0.01
11
65
5
96
0.52
0.78
1.0
1.1
—
—
—
0
0
249
2717
0.91
0.77
1.6
1.9
29.26
29.97
s
1.18
239
2627
6
107
0.56
0.72
1.0
1.1
—
222.50
—
0
20
97
1116
0.86
0.72
2.3
3.5
1.15
2.23
mmol/l
2.60
72
811
11
171
0.64
0.72
3.0
1.7
401.18
284.75
mu/l
0.27
11
161
21
287
0.73
0.71
1.6
1.9
1.94
1.68
mmol/l
0.43
21
278
18
126
1.43
0.70
1.5
1.8
7.14
7.96
mmol/l
0.70
18
126
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
21
283
0.74
0.66
1.1
1.3
—
—
—
0
0
31
241
1.29
0.66
26.5
6.9
8.37
7.39
mmol/l
0.62
22
203
8
129
0.62
0.64
3.1
2.6
48.25
30.09
mg/l
—
8
98
42
513
0.82
0.63
1.1
1.1
—
—
—
0
0
42
511
0.82
0.61
3.0
3.6
9.07
7.81
mmol/l
1.13
42
502
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
103
1161
0.88
0.60
9.1
6.2
24.77
24.46
mmol/l
0.38
97
1114
0
22
0.00
0.59
0.0
1.4
—
27.02
—
0
13
717
6910
1.06
0.58
4.2
4.7
59.73
74.98
ng/l
0.43
538
5494
28
354
0.79
0.58
1.2
1.4
—
—
—
0
0
517
5408
0.94
0.57
2.6
2.2
292.52
216.02
u/l
1.22
478
5085
5
86
0.58
0.56
1.0
1.2
102.00
90.14
u/l
—
5
77
5
87
0.57
0.56
1.0
1.2
30.80
25.86
u/l
—
5
79
25
317
0.79
0.54
1.3
1.4
—
—
—
0
0
11
159
0.69
0.54
1.3
1.4
12.36
14.06
u/l
0.78
11
145
9
132
0.68
0.52
1.2
1.2
—
54.22
—
0
9
6
100
0.60
0.51
1.0
1.6
—
—
—
0
0
11
157
0.70
0.51
1.2
1.6
—
—
—
0
0
663
6861
0.95
0.50
2.1
2.4
76.66
79.78
nmol/l
1.91
559
5996
7
111
0.63
0.48
1.3
1.1
94.43
95.37
%
—
7
101
156
1438
1.09
0.47
1.6
1.7
—
—
—
0
0
29
354
0.82
0.47
1.3
1.5
—
—
—
0
0
1079
10555
1.04
0.46
5.9
5.6
2646.61
2109.59
e6/l
0.14
41
182
477
4577
1.05
0.46
5.0
4.6
0.00
0.00
estimate
0.96
111
1539
5
82
0.61
0.45
1.0
1.2
—
—
—
0
0
5
82
0.61
0.45
1.0
1.2
—
—
—
0
0
5
85
0.59
0.45
1.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
11.9
—
5.46
—
0
15
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
15
194
0.77
0.40
1.1
1.2
233.00
156.91
miu/ml
—
5
69
22
271
0.81
0.40
1.3
1.2
—
—
—
0
0
11
149
0.74
0.40
1.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
4.5
—
—
—
0
0
756
7759
0.96
0.39
5.2
6.3
1.22
1.21
mmol/l
2.09
664
7076
0
19
0.00
0.39
0.0
1.6
—
5.77
—
0
14
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
48
548
0.87
0.39
4.3
3.7
1.13
1.69
index
0.65
32
281
11
148
0.74
0.38
1.2
1.7
—
—
—
0
0
16
202
0.79
0.36
1.6
1.5
—
—
—
0
0
25
207
1.21
0.36
1.9
2.1
1.40
1.66
u/field
—
10
100
5
77
0.65
0.35
1.0
1.2
—
—
—
0
0
6
42
1.43
0.35
1.3
1.1
104.67
274.70
iu/ml
—
6
42
622
6056
1.04
0.33
4.9
4.7
4.77
0.77
estimate
0.40
106
1445
854
8716
0.97
0.32
5.7
6.9
1.22
1.21
mmol/l
5.96
724
7433
21
252
0.83
0.32
1.5
1.5
—
—
—
0
0
171
1809
0.94
0.31
4.0
3.8
—
—
—
0
0
140
1491
0.93
0.31
2.8
2.5
0.27
0.55
e6/l
2.37
134
1433
48
536
0.89
0.30
1.2
1.3
—
—
—
0
0
11
84
1.31
0.30
1.9
1.8
0.17
2.64
u/field
—
6
60
11
141
0.78
0.29
1.1
1.1
—
—
—
0
0
17
206
0.82
0.29
1.1
1.4
—
—
—
0
0
8
110
0.73
0.28
1.8
1.5
3.75
7.04
u/l
—
8
89
9
120
0.75
0.27
1.8
1.6
—
—
—
0
0
17
204
0.83
0.27
1.1
1.4
—
—
—
0
0
777
7623
1.03
0.26
3.6
4.8
34.97
34.24
g/l
2.91
694
7034
182
1741
1.05
0.24
2.6
2.5
6.49
6.83
ug/l
0.07
123
1449
246
2551
0.96
0.23
1.8
1.9
—
—
—
0
0
42
380
1.11
0.23
1.2
1.2
—
—
—
0
0
5
39
1.28
0.23
1.0
1.4
18.80
12.18
mm/h
—
5
39
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
7.98
—
0
12
0
12
0.00
0.21
0.0
2.8
—
4.55
—
0
5
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
4693.17
—
0
6
0
13
0.00
0.21
0.0
1.2
—
97.62
—
0
13
42
383
1.10
0.20
1.2
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
17
197
0.86
0.19
1.1
1.4
—
—
—
0
0
17
197
0.86
0.19
1.1
1.4
—
—
—
0
0
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
17
196
0.87
0.18
1.1
1.4
—
—
—
0
0
18
206
0.87
0.18
1.1
1.4
—
—
—
0
0
1085
10959
0.98
0.17
22.8
26.4
330.61
330.17
g/l
0.85
1048
10827
74
700
1.06
0.16
2.0
2.1
1501.00
499.81
ug/l
1.22
66
658
34
370
0.92
0.16
2.1
2.3
18.99
79.93
ug/min
4.67
16
220
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
17
192
0.88
0.14
4.5
3.7
12.92
11.73
index
0.30
12
99
9
83
1.08
0.14
2.0
2.3
—
—
—
0
0
7
88
0.79
0.14
3.0
4.0
0.86
1.28
%
—
7
88
64
675
0.95
0.14
2.6
3.9
24.28
24.99
mmol/l
1.56
56
593
24
264
0.91
0.14
1.4
1.3
—
—
—
0
0
13
113
1.15
0.13
2.5
2.3
695.00
641.28
ml
—
8
67
9
107
0.84
0.13
1.1
1.2
58.67
98.54
u/l
—
9
90
43
457
0.94
0.12
1.8
2.3
126.63
124.80
g/l
0.24
38
355
334
3399
0.98
0.12
1.9
2.0
—
—
—
0
0
47
495
0.95
0.10
1.2
1.5
264.68
273.04
ug/g
0.12
31
311
44
417
1.06
0.10
1.8
1.6
0.33
0.33
mg/l
0.01
25
185
75
722
1.04
0.10
1.9
1.9
—
—
—
0
0
5
62
0.81
0.08
2.2
2.4
13.30
17.46
nmol/l
—
5
57
13
143
0.91
0.07
1.2
1.3
—
—
—
0
0
13
143
0.91
0.07
1.2
1.3
—
—
—
0
0
7
81
0.86
0.07
5.1
2.0
—
—
—
0
0
8
90
0.89
0.06
1.1
1.2
—
—
—
0
0
8
90
0.89
0.06
1.1
1.2
—
—
—
0
0
9
101
0.89
0.06
1.1
1.2
10.33
29.04
u/l
—
9
83
235
2378
0.99
0.05
1.9
1.9
—
—
—
0
0
13
141
0.92
0.05
2.0
1.4
38.00
67.27
titre
—
5
11
11
101
1.09
0.04
1.1
1.3
—
—
—
0
0
11
101
1.09
0.04
1.1
1.3
—
—
—
0
0
10
108
0.93
0.03
1.1
1.2
—
—
—
0
0
80
790
1.01
0.02
2.0
2.0
—
—
—
0
0
13
133
0.98
0.00
1.0
1.1
1.44
2.02
eliau/ml
—
7
41
19
188
1.01
0.00
4.4
2.8
—
—
—
0
0
17
174
0.98
0.00
1.7
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
939.72
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
7.68
—
0
6
9
99
0.91
-0.00
1.1
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
37.80
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
383.40
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
33.95
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
90
1.00
-0.00
2.0
3.0
13.44
13.35
%
—
9
90
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
66.22
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
9
96
0.94
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
8.54
—
0
7
9
96
0.94
-0.00
2.0
1.7
72.89
92.21
umol/l
—
9
96
0
7
0.00
-0.00
0.0
1.0
—
22.33
—
0
7
8
86
0.93
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
8
87
0.92
-0.00
1.1
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
7.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AD_EO – Alzheimer’s disease (Early onset)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).